Tag: AMAGINE

Brodalumab onset of action is significantly faster than ustekinumab: Results from the phase 3 AMAGINE-2 and -3 studies

Presented By
Dr Sandra Philipp, Charité-Universitätsmedizin Berlin, Germany
Trial
Phase 3, AMAGINE
Conference
SPIN 2019
Type
Peer-reviewed article

21 June 2019 21:59

Sustained and complete responses from the phase 3 AMAGINE-2 and -3 studies

Presented By
Prof. Lluís Puig, Hospital de la Santa Creu i Sant Pau, Spain
Trial
Phase 3, AMAGINE
Conference
SPIN 2019
Type
Peer-reviewed article

21 June 2019 15:29
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com